Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Beta-protein”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03522129
What this trial is testing

Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cognition Therapeutics 3
Early research (Phase 1)Ended earlyNCT00968097
What this trial is testing

Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition

Who this might be right for
Alzheimer's Disease
Institute for Neurodegenerative Disorders 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789873
What this trial is testing

A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Galimedix Therapeutics Inc 100
Testing effectiveness (Phase 2)Looking for participantsNCT05774704
What this trial is testing

Curcumin and Retinal Study

Who this might be right for
BioavailabilityGut MicrobiomeSafety
Texas Tech University Health Sciences Center 60
Very early researchEnded earlyNCT01000870
What this trial is testing

Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 6
Post-approval studies (Phase 4)Study completedNCT00551161
What this trial is testing

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Northwell Health 12
Not applicableStudy completedNCT07294586
What this trial is testing

Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementiaNeurodegenerative Disorders+5 more
Amoneta Diagnostics SAS 200
Early research (Phase 1)Ended earlyNCT00605059
What this trial is testing

Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 3
Early research (Phase 1)Active Not RecruitingNCT05642429
What this trial is testing

Study of AV-1959D, an Amyloid Beta Vaccine

Who this might be right for
Alzheimer Disease
Institute for Molecular Medicine 48
Testing effectiveness (Phase 2)Study completedNCT02576639
What this trial is testing

Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 124
Not applicableLooking for participantsNCT07402356
What this trial is testing

VR Pupillometry in Cognitive Impairment

Who this might be right for
Alzheimer s DiseaseMajor Depressive Disorder (MDD)Mild Cognitive Impairment+1 more
Max-Planck-Institute of Psychiatry 140
Not applicableLooking for participantsNCT06733714
What this trial is testing

Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults

Who this might be right for
Cognitive DysfunctionAlzheimer DiseaseMild Cognitive Impairment+8 more
Universidade Federal do Rio de Janeiro 40
Early research (Phase 1)Ended earlyNCT00886951
What this trial is testing

Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Institute for Neurodegenerative Disorders 2
Early research (Phase 1)Not Yet RecruitingNCT07458620
What this trial is testing

Prospective Single-Arm Safety Study of Cervical LVA in AD Patients

Who this might be right for
Alzheimer's Disease (AD)
Chang Gung Memorial Hospital 35
Early research (Phase 1)Study completedNCT00214851
What this trial is testing

The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria

Who this might be right for
Familial Cold Urticaria
Nova Scotia Health Authority 8
Early research (Phase 1)Study completedNCT02360657
What this trial is testing

Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia

Who this might be right for
Alzheimer's Disease
Janssen Pharmaceutical K.K. 18
Testing effectiveness (Phase 2)Study completedNCT00750282
What this trial is testing

Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers

Who this might be right for
Alzheimer DiseaseAmyloid Beta-Protein
Lantheus Biosciences Ltd. 422
Not applicableUnknownNCT02814422
What this trial is testing

Triglyceride-rich Lipoprotein and Development of Dementia

Who this might be right for
Dementia
National Taiwan University Hospital 1,000
Early research (Phase 1)Study completedNCT00456417
What this trial is testing

Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimers Disease
Institute for Neurodegenerative Disorders 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT06911944
What this trial is testing

Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

Who this might be right for
Down Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer Disease+1 more
Michael Rafii, MD, PhD 60
Next Page